Search results
Emcure Pharma IPO: Namita Thapar-backed issue may debut with 30% gains amid high investor interest -...
CNBC TV18· 5 days agoThe grey market premium (GMP) of Emcure Pharmaceuticals has jumped sharply following the closure of...
Day after heavy rains, Mumbai gets back to normalcy: Top updates in 5 points
Indian Express· 5 days agoMumbai witnessed grey skies on Tuesday morning, but the rains took a break today. In light of the...
Donald Trump shooting: Focus to shift on shooter and security lapses
The Hindu· 2 hours agoFormer president Donald Trump was the target of an apparent assassination attempt on July 13 at a...
The best evergreen plants for pots - ensure year-round colour in your garden with these smart...
Ideal Home· 20 hours agoCredit: Alamy The best evergreen plants for pots ensure that there is always something of interest...
This AI tool may outperform clinical tests at detecting Alzheimer’s
Mid Day· 23 hours agoScientists at the Cambridge University in the UK have developed an artificial intelligence...
Rohit Sharma makes Wimbledon Centre Court debut, sets social media abuzz
Indian Express· 21 hours agoA few days after winning the T20 World Cup, Indian cricket team captain Rohit Sharma was spotted at...
When love stops being easy
Indian Express· 6 hours agoRekha and Raghav Subramaniam were childhood sweethearts. Despite being devoted parents and deeply connected to their families — taking on the responsibility of raising the daughter of Raghav ...
These 2 soon-to-list SME IPOs are boasting a GMP of over 100% despite NSE price cap
The Economic Times· 4 days agoDespite the pricing cap on listings for SME IPOs, there seems to be no effect on the grey market...
Bansal Wire IPO listing likely at a 25-30% premium; What should you do next? - CNBC TV18
CNBC TV18· 5 days agoBansal Wire Industries Ltd., a stainless-steel wire manufacturing company, is likely to make a...
Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely
Business Today· 4 days agoShares of Emcure Pharma were commanding a grey market premium of Rs 390-400 on the last day of the...